Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.

by Gretja Schnell, Preethi Krishnan, Rakesh Tripathi, Jill Beyer, Thomas Reisch, Michelle Irvin, Tatyana Dekhtyar, Liangjun Lu, Teresa I Ng, Wangang Xie, Tami Pilot-Matias, Christine Collins
Published 2018-01-01

Emergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015

by Jinhua Song, Yan Zhang, Huiling Wang, Jing Shi, Liwei Sun, Xiaojie Zhang, Zifeng Yang, Wenda Guan, Hong Zhang, Pengbo Yu, Zhengde Xie, Aili Cui, Teresa I. Ng, Wenbo Xu
Published 2017-07-01

Emergence of BA9 genotype of human respiratory syncytial virus subgroup B in China from 2006 to 2014

by Jinhua Song, Huiling Wang, Jing Shi, Aili Cui, Yanzhi Huang, Liwei Sun, Xingyu Xiang, Chaofeng Ma, Pengbo Yu, Zifeng Yang, Qi Li, Teresa I. Ng, Yan Zhang, Rongbo Zhang, Wenbo Xu
Published 2017-12-01

Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 Infection

by Teresa I. Ng, Tami Pilot-Matias, Rakesh Tripathi, Gretja Schnell, Preethi Krishnan, Thomas Reisch, Jill Beyer, Tatyana Dekhtyar, Michelle Irvin, Liangjun Lu, Armen Asatryan, Andrew Campbell, Betty Yao, Sandra Lovell, Federico Mensa, Eric J. Lawitz, Jens Kort, Christine Collins
Published 2018-08-01

P49 MAGELLAN-1, PART 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic HCV genotype 1 or 4 and prior direct-acting antiviral treatment failure

by Fred Poordad, Stanislas Pol, Armen Asatryan, Maria Buti, David Shaw, Christophe Hézode, Franco Felizarta, Robert W. Reindollar, Stuart C. Gordon, Stephen Pianko, Michael W. Fried, David E. Bernstein, Joel Gallant, Chih-Wei Lin, Yang Lei, Teresa I. Ng, Tami Pilot-Matias, Jens Kort, Federico Mensa
Published 2017-08-01